Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioHarvest SciencesBHST -17.32%64 3-Year EBITDA Growth Rate is 19.50% as of Mar. 2026, which is 31% above its 10-year median of 14.90. GuruFocus rates BHST with a GF Score™ of 64/100 and a GF Value™ of $8.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,661 Consumer Packaged Goods companies, BioHarvest Sciences ranks better than 69.05% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 19.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 10.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -1.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioHarvest Sciences was 43.30% per year. The lowest was -102.10% per year. And the median was 14.90% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
BioHarvest Sciences 3-Year EBITDA Growth Rate Related Terms
BHST vs BFNH, LSF, HAIN: 3-Year EBITDA Growth Rate Comparison
For the Packaged Foods subindustry, BioHarvest Sciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 19.50% mean?
BioHarvest Sciences (BHST) has a 3-Year EBITDA Growth Rate of 19.50% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BioHarvest Sciences and its competitors. This is 31% above median its historical median of 14.90. According to the industry distribution chart, BioHarvest Sciences ranks #514 out of 1661 companies in the Consumer Packaged Goods industry, placing it in the top 30.9%.
Is BioHarvest Sciences' 3-Year EBITDA Growth Rate too high?
BioHarvest Sciences' current 3-Year EBITDA Growth Rate of 19.50% is 31% above median its 10-year median of 14.90. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 8.00. BioHarvest Sciences' value of 19.50% is 143.8% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #514 out of 1661 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, BioHarvest Sciences has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' 3-Year EBITDA Growth Rate compare to BFNH and LSF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #514 out of 1661 companies for 3-Year EBITDA Growth Rate. This puts BioHarvest Sciences in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.00. BioHarvest Sciences' value of 19.50% is 143.8% above this benchmark. While the company's 10-year median is 14.90 vs. the industry median of 8.00, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.00, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current 3-Year EBITDA Growth Rate of 19.50% is 143.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current 3-Year EBITDA Growth Rate is 19.50%, which is 31% above median its own 10-year median of 14.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.67, compared to a current price of $2.10 — trading 75.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 19.50%, which is 31% above median its 10-year median of 14.90 and 143.8% above the Consumer Packaged Goods industry median of 8.00. BioHarvest Sciences' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current 3-Year EBITDA Growth Rate is 19.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.10 is trading 75.8% below its estimated GF Value™ of $8.67.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
3-Year EBITDA Growth Rate: 19.50% (31% above median its 10-year median of 14.90)
GF Value™: $8.67 vs. price of $2.10 (75.8% below fair value)
Industry Position: 143.8% above the Consumer Packaged Goods median (#514 of 1661)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
64GF Score
Get the complete analysis for BHST
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
